Mental health disorders are increasing at staggering rates, particularly in the United States with upwards of 10 million Americans having unmet needs for mental healthcare. There has been a misguided assumption that digital solutions could not address mental health issues. Yet a host of innovative initiatives with chatbots and digital CBT suggest the contrary: in many cases, both perceived stigma and financial hurdles are driving interest in mental health support from bots, and in some cases, this option is preferred to human contact.
ObvioHealth’s experienced clinical team and innovative technology position us to effectively conduct successful mental health studies. Our platform and app integrate with a range of AI-supported devices. Our virtual site team is available to provide support and assistance, giving sponsors and patients both the human and tech options to suit their needs. The result is better, real world data to improve mental health research.
Read more below to see how we do it.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels and sleep. The study revealed that parents of preemies need more mental health support.Read Full Case Study
ObvioHealth developed a master protocol for a multinational food company that included a study design with device integration and specific ePRO questionnaires.Read Full Case Study
Our proprietary application brings clinical research into people’s homes, making it easier for them to participate, and easier for researchers to collect robust data that reflect real behaviors.
Recruitment is often a huge barrier to trial success. ObvioHealth uses digital targeting methods to find untapped populations. We identify the online behaviors that point to people with a positive pre-disposition for a specific trial and, because our studies are virtual, we are not geographically tied to a site location.
Once recruited, we enroll participants through virtual prescreening/screening and e-consent. This eliminates the burdensome cost of site retention and staffing requirements, and often shortens the recruitment period.
The ObvioHealth platform and app incorporate multiple data capture technologies to adapt to the needs of any given trial. These include simple survey-type completion of questionnaires and diaries, image, video and audio capture and use of wearables. Complementary data collection methods ensure more robust data real world outcomes.
Our platform makes it easy to trigger, track and manage products and payment of incentives. ObvioHealth can reimburse participants with the stipend program that is fully virtual. We ship any needed study supplies or devices directly to the participant’s home.
An important advantage of ObvioHealth’s app is the real time remote monitoring of medication adherence and potential adverse events. Our escalating system of reminders and immediate AE/SAE detection make our studies safer, while also improving medication adherence.
Our easy-to-use, convenient app makes it easier for people to remain compliant. There is little to no time wasted travelling to clinical sites, so there are fewer dropouts. All of this means that studies end on time or ahead of schedule. And because participants are able to report more real world and real time experiences, the resulting data is more accurate and reliable.